SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-043783 from Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)

Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Nov. 6, 2024 · CIK: 0001106838 · Accession: 0001493152-24-043783

AI Filing Summary & Sentiment

File numbers found in text: 333-282850

Date
November 6, 2024
Author
Capital Markets, LLC
Form
CORRESP
Company
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)

Letter

RE:

November 6, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, DC 20549

Sonnet BioTherapeutics Holdings, Inc. (CIK 0001106838) (the “Company”)

Registration Statement No. 333-282850 on Form S-1 (the “Registration Statement”)

Ladies and Gentlemen:

On November 6, 2024, we, as the representative of the underwriters, filed a letter with the U.S. Securities and Exchange Commission via EDGAR requesting, pursuant to Rule 461 under the Securities Act of 1933, as amended, the acceleration of the effective date of the above-referenced Registration Statement so that it may be declared effective at 5:00 p.m., Eastern Time, on November 6, 2024, or as soon practicable thereafter. We are no longer requesting that such Registration Statement be declared effective at this specific date and time and we hereby formally withdraw such request for acceleration.

Very
truly yours,
Chardan
Capital Markets, LLC

Show Raw Text
CORRESP
1
filename1.htm

November
6, 2024

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
DC 20549

    RE:

    Sonnet
    BioTherapeutics Holdings, Inc. (CIK 0001106838) (the “Company”)

    Registration
    Statement No. 333-282850 on Form S-1 (the “Registration Statement”)

Ladies
and Gentlemen:

On
November 6, 2024, we, as the representative of the underwriters, filed a letter with the U.S. Securities and Exchange Commission via
EDGAR requesting, pursuant to Rule 461 under the Securities Act of 1933, as amended, the acceleration of the effective date of the above-referenced
Registration Statement so that it may be declared effective at 5:00 p.m., Eastern Time, on November 6, 2024, or as soon practicable thereafter.
We are no longer requesting that such Registration Statement be declared effective at this specific date and time and we hereby formally
withdraw such request for acceleration.

    Very
    truly yours,

    Chardan
    Capital Markets, LLC

    on
    behalf of itself and as representative of the Underwriters

    By:
    /s/
    Shai Gerson

    Name:
    Shai
    Gerson

    Title:
    Managing
    Partner